We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HFFG icon
4026
HF Foods Group
HFFG
$80.2M
$41K ﹤0.01%
6,081
-37,871
-86% -$262K
IHRT icon
4027
iHeartMedia
IHRT
$543M
$41K ﹤0.01%
+2,156
New +$43K
KRUS icon
4028
Kura Sushi USA
KRUS
$560M
$41K ﹤0.01%
+733
New +$37.9K
NUVL
4029
DELISTED
Nuvalent
NUVL
$41K ﹤0.01%
+2,976
New +$43.2K
PRCT icon
4030
Procept Biorobotics
PRCT
$1.06B
$41K ﹤0.01%
+1,175
New +$28.3K
SNCR
4031
DELISTED
Synchronoss Technologies
SNCR
$41K ﹤0.01%
2,610
RPT
4032
Rithm Property Trust
RPT
$95.8M
$41K ﹤0.01%
593
-3,801
-87% -$277K
VIRX
4033
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$41K ﹤0.01%
+8,554
New +$25.8K
CODX
4034
Co-Diagnostics
CODX
$5.31M
$40K ﹤0.01%
216
HBIO icon
4035
Harvard Bioscience
HBIO
$27.5M
$40K ﹤0.01%
638
-4,131
-87% -$244K
NWPX icon
4036
NWPX Infrastructure Inc
NWPX
$1.19B
$40K ﹤0.01%
1,584
-10,176
-87% -$293K
PRLD icon
4037
Prelude Therapeutics
PRLD
$366M
$40K ﹤0.01%
+5,877
New +$53.8K
VTGN icon
4038
VistaGen Therapeutics
VTGN
$9.89M
$40K ﹤0.01%
1,050
-6,800
-87% -$296K
ASZ.WS
4039
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$40K ﹤0.01%
+71,667
New +$44.9K
VTAQR
4040
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$40K ﹤0.01%
+220,918
New +$37.2K
EMKR
4041
DELISTED
Emcore Corp
EMKR
$40K ﹤0.01%
1,055
-3,899
-79% -$187K
AREC icon
4042
American Resources Corp
AREC
$191M
$39K ﹤0.01%
15,000
CDTX
4043
DELISTED
Cidara Therapeutics
CDTX
$39K ﹤0.01%
2,371
COOK icon
4044
Traeger
COOK
$178M
$39K ﹤0.01%
+105
New +$50K
KRRO icon
4045
Korro Bio
KRRO
$150M
$39K ﹤0.01%
+370
New +$70.7K
PSQ icon
4046
ProShares Short QQQ
PSQ
$824M
$39K ﹤0.01%
676
SPRU icon
4047
Spruce Power Holding Corp
SPRU
$35.8M
$39K ﹤0.01%
+2,464
New +$42.9K
SSTI icon
4048
SoundThinking
SSTI
$100M
$39K ﹤0.01%
1,417
-8,869
-86% -$242K
USLM icon
4049
United States Lime & Minerals
USLM
$3.16B
$39K ﹤0.01%
1,685
-10,860
-87% -$262K
NTCO
4050
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$39K ﹤0.01%
+3,609
New +$32K

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.